Ship in Europe, Find out rates!
Chewable tablets based on simethicone.
Simecrin is used in the symptomatic treatment of gastrointestinal bloating and adult aerophagia.
The drug should be taken according to the following doses and methods: 2 tablets per day (1 at the end of each main meal). The tablets must be chewed.
No overdose phenomena have been reported with the use of Simecrin.
No undesirable effects due to Simecrin were reported.
There are no adequate data on the use of Simecrin in pregnant women, therefore it should not be used in pregnancy unless clearly needed and after the benefit / risk assessment by the physician.
It is not known whether simethicone is excreted in human milk. The excretion of simethicone into breast milk has not been studied in animals. A decision on whether to continue / discontinue simethicone therapy must be made taking into account the benefit of breastfeeding for the infant and the benefit of simethicone therapy for the woman.
Do not exceed the recommended dose. After a short period of treatment without appreciable results, consult your doctor. The chewable tablets contain lactose: patients with rare hereditary problems of galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medicine.
Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored. Store the medicine in the original package protected from light and moisture.
Warning : do not use the medicine after the expiry date indicated on the package.
Each Simecrin tablet contains:
Simethicone 120 mg
Mannitol, colloidal hydrated silica, pregelatinised starch, lactose monohydrate, polyvinylpyrrolidone K30, crospovidone, talc, magnesium stearate, mint flavor.